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Purpose: We used the Swedish interactive threshold algorithms (SITA) standard strategy of Humphrey perimetry, to 
analyze the pattern of visual field (VF) defects and evaluate the quantitative correlation between the tumor vol-
ume and severity of VF defects in patients with pituitary macroadenoma. 
Methods: We reviewed 50 patients with pituitary macroadenoma who received VF test and 11 patients were 
excluded. VF analysis was performed with Humphrey perimeter using the SITA standard strategy. The tumor vol-
ume was assessed radiologically via brain magnetic resonance images and was calculated using Cavalieri’s 
principle. We used the mean deviation (MD) and pattern standard deviation (PSD) of the Humphrey parameter to 
measure VF defect severity, and then analyzed the correlation of tumor volume with VF defects. 
Results: Twenty nine patients (74%) showed abnormal VF and bitemporal field changes, which were the most com-
mon field defects on presentation. Seven patients (18%) had unilateral VF defects, 22 patients (56%) had bi-
lateral VF defects. The tumor volume of the patients with VF defects was significantly larger than that of patients 
with normal VF (p = 0.006). The tumor volume exhibited significant negative correlation with MD (r = -0.693; p < 
0.001) and significant positive correlation with PSD (r = 0.589; p < 0.001). 
Conclusions: In patients with pituitary macroadenoma, there was a variety of VF defects and a high correlation be-
tween the tumor volume and the severity of VF defects. SITA standard strategy can be a fast and quantitative 
method for evaluating central VF defects.
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Pituitary adenomas account for approximately 12% of 
clinically symptomatic intracranial tumors [1]. They are 
classified into two categories based on their size, micro-
adenoma (less than 1 cm) and macroadenoma (greater than 1 
cm) [2]. Pituitary macroadenoma can cause visual field (VF) 
defects by compressing the optic chiasm or the optic nerve. 
The prevalence of VF defects in pituitary adenoma varies, 
ranging from 9% to 32% as reported in the literature [1,3,4]. 
Because of its anatomical relationship with the optic chiasm, 
pituitary adenoma typically results in bitemporal hemianopia. 
However, according to tumor size and optic chiasmal posi-
tion, a variety of field defects can be produced by pituitary 
adenoma
 and the tumor size is a significant factor for the se-
verity of VF defects [5,6].
Goldmann perimetry has been classically considered to be 
the standard perimetry technique in neuro-ophthalmology. 
However, several studies reported that most automated peri-
metry was similar or more sensitive than Goldmann perimetry 
in detecting and quantifying VF defects in neuro-ophthalmol-
ogy [7-9]. Recent studies have the Humphrey’s full-threshold 
strategy, however it requires a higher level of understanding 
and greater concentration by the patient [10,11]. The Swedish 
interactive threshold algorithms (SITA) family of automated 
perimetry is the most recently developed and most widely 
used program resulting in a much shorter VF testing process 
that is easier for the patient [12]. 
To the best of our knowledge, there has been no study spe-
cifically designed to evaluate the results of SITA strategy in 
patients with pituitary adenoma. Using the Humphrey’s Korean J Ophthalmol Vol.25, No.1, 2011
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Table 1. Baseline characteristics of the patients with pituitary 
macroadenoma
Variable Value 
No. of patients 39
Male:Female 24:15
Age (yr) 45.8 ± 15.6 (19-86)
Test time per eye (min) 5.87 ± 1.38 (4.5-8.75)
Mean deviation (dB)   -9.09 ± 6.85 (-23.47--0.02)
Pattern standard deviation (dB) 6.61 ± 4.15 (1.18-16.15)
Tumor volume (cm
3) 8.71 ± 6.79 (1.02-33.20)
Values are means ± SD (range).
Fig. 1. Humphrey visual field shows right incongruous homon-
ymous hemianopia. Gadolinium-enhanced, T1-weighted magnetic 
resonance images of the brain reveal a mass that involves the optic 
tract.
SITA standard strategy, we analyzed the pattern of VF de-
fects and evaluated the correlation between the tumor vol-
ume and severity of VF defects quantitatively in patients 
with pituitary macroadenoma. 
Materials and Methods
We retrospectively reviewed the medical records of 50 pa-
tients with pituitary macroadenoma who received VF tests in 
the Department of Ophthalmology and Neurosurgery, 
Hallym University Sacred Heart Hospital, between August 
2000 and June 2008. Eleven patients were excluded because 
of unreliable VF test results (three patients) or other oph-
thalmologic disease (eight patients). Our analysis was thus 
based on the remaining 39 cases. The diagnosis of pituitary 
macroadenoma was determined by the results of brain mag-
netic resonance images (MRI). 
The patients underwent a complete ophthalmologic ex-
amination including best-corrected visual acuity (BCVA), 
slit lamp biomicrosopy, applanation tonometry, fundus ex-
amination and VF test. Patients with ophthalmologic disease 
or other disease affecting the results of VF test, whose BCVA 
results were lower than 20/80 in both eyes, and those with re-
currence of tumor following previous treatment were excluded.
A VF test was performed before surgery or medication for 
pituitary macroadenoma with a Humphrey field analyzer 750 
(Zeiss-Humphrey, Dublin, CA, USA) using a 4 mm
2 Goldmann 
size III stimulus. The 24-2 SITA standard strategy was used. 
Each patient underwent VF tests twice on separate days the 
more reliable result was selected for statistical analysis. The 
reliability criteria used were fixation losses less than 20%, as 
well as false positive and false negative errors less than 15%. 
VF examinations were considered abnormal if pattern standard 
deviation (PSD) or glaucoma hemifield test was abnormal. 
Based on either of the following criteria
 [13], quadranopsia 
was defined. 
1) Depression of thresholds by 5 dB or more, in three or 
more contiguous points adjacent to the vertical meridian in 
the involved quadrant as compared to their mirror image 
points across the vertical meridian. 
2) The pattern deviation plot showed three or more points 
adjacent to the vertical meridian in the involved quadrant de-
pressed to the 1% probability level with normal mirror image 
points across the vertical meridian. 
For the diagnosis of hemianopsia, the diagnostic criteria 
for quadranopsia had to be applicable to both quadrants com-
prising the hemifield. To quantify the severity of VF defects, 
we used results for the mean deviation (MD) and PSD of both 
eyes. The tumor volume was assessed radiologically on a 
brain MRI by the same neuroradiologist. For the estimation 
of tumor volume, it was assumed that pituitary tumors had an 
ellipsoid form [14]. Using Cavalieri’s principle, pituitary tu-
mor volume was calculated after performing measurements 
of tumor diameter in three orthogonal planes, using the fol-
lowing formula: tumor volume = 4/3π (a/2·b/2·c/2) (where 
a,b, and c represent the diameters in the three dimensions).
Statistical analysis was performed using SPSS ver. 12.0 
(SPSS Inc., Chicago, IL, USA). To compare groups, a chi-square 
test used for categorical variables and Mann-Whitney U-test 
were used for continuous variables. Pearson’s correlation 
analysis was used to assess for relationships between tumor 
volume and MD and between tumor volume and PSD. All 
tests of association were considered statistically significant 
when p < 0.05.
Results
Among the 39 patients, 24 were male and 15 were female. 
The mean age was 45.8 ± 15.6 years, ranging from 19 to 86 
years. The MD was -9.09 ± 6.85 dB and the PSD was 6.61 ± 
4.15 dB. The baseline characteristics of the study partic-
ipants are shown in Table 1.
Types of VF defects in the patients are summarized in 
Table 2. Ten patients (26%) had normal VF and 29 patients 
(74%) had abnormal VF. Among the abnormal VF, seven pa-
tients (18%) had unilateral VF defects, and 22 patients (56%) 
had bilateral VF defects. Most of bilateral VF defects were 
bitemporal hemianopsia. Interestingly there were three pa-
tients with homonymous hemianopsia. These patients had a 
giant mass that involved the optic tract, one of which is 
shown in Fig. 1. 
A comparison between patients with and without VF de-
fects linked to the pituitary macroadenoma is summarized in 
Table 3. There were no statistically significant differences in JP Lee, et al. Visual Field of Pituitary Macroadenoma
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Table 2. Types of visual field defects in patients with pituitary macroadenoma
Characteristic No. of patients (%)
Normal visual field 10 (26)
Abnormal visual field  29 (74)
     Unilateral defect  7 (18)
         Temporal hemianopsia   4
         Superotemporal quadranopsia   3
     Bilateral defect 22 (56)
         Bitemporal hemianopsia  12
         Hemianopsia in one eye, superotemporal quadranopsia in other eye   3
         General reduction in one eye, temporal defect in other eye   3
         Homonymous hemianopsia   3
         Others  1
Table 3. Comparison between patients with and without visual field defects
Variable Patients with normal visual field (n=10) Patients with visual field defect (n=29) p-value
Male:Female 6:4   18:11 0.908
Age (yr) 37.40 ± 13.35    48.76 ± 15.38 0.051
Tumor volume (cm
3) 3.32 ± 2.29  10.57 ± 6.85 0.006
Mean deviation (dB) -1.83 ± 1.22 -11.59 ± 6.15 < 0.001
Pattern standard deviation (dB) 2.14 ± 1.58    8.15 ± 3.61 0.01
Values are means ± SD.
Fig. 2. Correlation between mean deviation (MD) and tumor vol-
ume in patients with pituitary macroadenoma. Pearson correlation 
coefficient = -0.693, p < 0.001. 
Fig. 3. Correlation between pattern standard deviation (PSD) and 
tumor volume in patients with pituitary macroadenoma. Pearson 
correlation coefficient = 0.589, p < 0.001.
sex (p = 0.908) and age (p = 0.051) between the two groups. 
However, the tumor volume of the patients with VF defects 
was significantly larger than patients with normal VF (p = 
0.006). In patients with VF defects, the MD was significantly 
lower (p < 0.001) and the PSD was significantly higher (p = 
0.01) than patients with normal VF. 
The correlation between MD and tumor volume is shown 
in Fig. 2. The tumor volume exhibited significant negative 
correlation with MD (r = -0.693; p < 0.001). The correlation 
between PSD and tumor volume is shown in Fig. 3. The tumor 
volume exhibited a significant positive correlation with PSD 
(r = 0.589; p < 0.001). 
Discussion
Pituitary adenomas can cause visual loss or VF defects by Korean J Ophthalmol Vol.25, No.1, 2011
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compressing the optic chiasm or the optic nerve. Because le-
sions that damage the body of the optic chiasm characteristi-
cally produce bitemporal hemianopia [15], bitemporal field 
changes were the most common field defects on presentation 
in pituitary adenoma. However, according to tumor size and 
optic chiasmal position, a variety of field defects from mon-
ocular superior temporal defects to bilaterally constricted 
fields can be produced [6].
 In our study, there were 29 pa-
tients (74%) with VF defects and bitemporal hemianopsia 
was also the most common type. In addition, there were sev-
en monocular VF defects respecting the vertical meridian 
and three homonymous hemianopsia. Hershenfeld and 
Sharpe [16] reported that the cause of 64% of monocular 
hemianopsia was pituitary adenoma and several authors re-
ported that it can cause homonymous hemianopsia [6,17].
 
Therefore brain imaging should be considered if patients 
showed not only binocular but also monocular VF defects re-
specting the vertical meridian. 
Currently the automated perimetry is the gold standard for 
VF testing and most automated perimetry is superior to 
Goldmann perimetry in terms of sensitivity and quantifica-
tion of the VF defects [7,18,19]. In addition, many studies 
showed that automated perimetry was comparable to 
Goldmann perimetry in detecting VF abnormalities in neuro-
logical diseases [7-9]. A recent study compared SITA Fast 
strategy with Goldmann perimetry in the detection and char-
acterization of VF defects in neuro-ophthalmic practice [20].
 
They showed that the SITA Fast strategy was useful in de-
tection and quantification of central VF defects, and might be 
preferable to Goldmann perimetry in patients with neu-
ro-ophthalmic disorders. 
There are few studies which evaluated automated peri-
metry in patients with pituitary adenoma [13,21]
 and these 
studies used the full-threshold strategy. An increased varia-
bility of the full-threshold strategy has been demonstrated in 
elderly populations and patients with VF defects [22,23]. In 
our study, we used a SITA strategy that was recently devel-
oped and shortens testing time for the standard Humphrey 
strategy but does not seem to affect variability [12]. It is 
known that increasing the test duration may influence the ac-
curacy of the information obtained because of visual fatigue. 
For examination of the central 30
o o f  V F  i n  n o r m a l  i n -
dividuals, the SITA standard reduced the test time by up to 
50% in comparison with the full-threshold strategy [24,25]. 
In our study, the average test time of the central 24
o of VF was 
only 5.87 minutes per eye. 
The relationship of pituitary tumor size and VF defects has 
been reviewed in several studies. Rivoal et al. [6] demon-
strated that patients with VF abnormality had larger tumors 
and only the size of the adenoma was a significant factor for 
VF defects. Thomas et al. [13] demonstrated that the severity 
of field defects and visual loss were related to tumor size. 
Our results support those of previous studies that there is 
close correlation between tumor size and VF defects. 
However, we used different parameters from previous stud-
ies to evaluate a more accurate correlation. Because a tumor 
is a three dimensional structure, we measured the tumor by 
volume not by area. To quantify VF defects, we used the MD 
and PSD values of Humphrey perimeter. MD provides useful 
information concerning overall abnormality of a single field, 
as well as information regarding the worsening or improve-
ment of fields over time. PSD shows the pattern of a localized 
abnormality [26]. Both of the parameters are expressed nu-
merically, so those are useful to quantify the VF defects more 
accurately. Gedik et al. [21] also used the MD and PSD for 
evaluating VF defects and found there was no significant cor-
relation between tumor size and MD or PSD. However dif-
ferent from our study, they used a 30-2 full-threshold strategy. 
As mentioned above, full-threshold strategy has some weak-
nesses and in the peripheral rim of points, a 30-2 program could 
have edge or lens rim artifact and response variability [26].  
In summary, we used the SITA strategy to analyze VF of 
pituitary macroadenoma. Like the results of other VF programs, 
most of the VF defects were monocular or binocular hemi-
anopsia respecting the vertical meridian. Furthermore, using 
the Humphrey parameters we measured VF defects quantita-
tively and there was a high correlation between the tumor 
volume and the severity of VF defects. We think the SITA 
strategy can be a fast and quantitative method in evaluating 
central VF defects of patients with pituitary macroadenoma.
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